Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Retained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Pliant Therapeutics (PLRX) Non-Current Deffered Revenue (2019 - 2020)

Pliant Therapeutics (PLRX) has disclosed Non-Current Deffered Revenue for 2 consecutive years, with $581000.0 as the latest value for Q4 2020.

  • On a quarterly basis, Non-Current Deffered Revenue rose 26.86% to $581000.0 in Q4 2020 year-over-year; TTM through Dec 2020 was $581000.0, a 26.86% increase, with the full-year FY2020 number at $581000.0, up 26.86% from a year prior.
  • Non-Current Deffered Revenue was $581000.0 for Q4 2020 at Pliant Therapeutics, up from $565000.0 in the prior quarter.
  • In the past five years, Non-Current Deffered Revenue ranged from a high of $581000.0 in Q4 2020 to a low of $458000.0 in Q4 2019.